Stock VIKRAMTH6 VIKRAM THERMO (INDIA) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vikram Thermo (India) Limited

Equities

VIKRAMTH6

INE337E01010

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:55 13/05/2024 BST 		5-day change 1st Jan Change
204.6 INR +1.46% Intraday chart for Vikram Thermo (India) Limited -0.75% +30.31%
02-13 Vikram Thermo Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Vikram Thermo Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 583.4 418.7 445 1,029 1,226 1,917
Enterprise Value (EV) 1 702 532.5 475.7 1,029 1,254 1,957
P/E ratio 24.9 x 9.46 x 5.99 x 8.52 x 14.1 x 11.3 x
Yield 0.48% 2% 2.11% 0.91% 0.77% 0.82%
Capitalization / Revenue 1.2 x 0.72 x 0.8 x 1.4 x 1.32 x 1.72 x
EV / Revenue 1.44 x 0.91 x 0.85 x 1.4 x 1.35 x 1.75 x
EV / EBITDA 13.7 x 5.95 x 4.01 x 5.69 x 8.55 x 7.43 x
EV / FCF -12.3 x -242 x 17.9 x 38.7 x -25.3 x -83.4 x
FCF Yield -8.13% -0.41% 5.58% 2.58% -3.95% -1.2%
Price to Book 1.51 x 0.98 x 0.82 x 1.57 x 1.67 x 2.14 x
Nbr of stocks (in thousands) 27,913 27,913 31,358 31,358 31,358 31,358
Reference price 2 20.90 15.00 14.19 32.80 39.09 61.12
Announcement Date 01/10/18 23/08/19 18/08/20 24/08/21 24/08/22 16/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 486.1 582.4 558.5 735.9 925.7 1,115
EBITDA 1 51.13 89.52 118.5 180.8 146.7 263.2
EBIT 1 35.66 71.34 98.89 161.1 119.3 231.4
Operating Margin 7.34% 12.25% 17.71% 21.89% 12.88% 20.75%
Earnings before Tax (EBT) 1 31.16 61.62 94.46 159.9 117.7 230.4
Net income 1 23.44 44.29 72.37 120.7 86.9 169.1
Net margin 4.82% 7.6% 12.96% 16.4% 9.39% 15.16%
EPS 2 0.8397 1.586 2.370 3.848 2.771 5.390
Free Cash Flow 1 -57.08 -2.201 26.56 26.57 -49.55 -23.48
FCF margin -11.74% -0.38% 4.76% 3.61% -5.35% -2.1%
FCF Conversion (EBITDA) - - 22.41% 14.69% - -
FCF Conversion (Net income) - - 36.7% 22.02% - -
Dividend per Share 2 0.1000 0.3000 0.3000 0.3000 0.3000 0.5000
Announcement Date 01/10/18 23/08/19 18/08/20 24/08/21 24/08/22 16/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 119 114 30.7 0.11 28.1 40.1
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.321 x 1.271 x 0.259 x 0.000614 x 0.1915 x 0.1524 x
Free Cash Flow 1 -57.1 -2.2 26.6 26.6 -49.5 -23.5
ROE (net income / shareholders' equity) 6.17% 10.9% 14.9% 20.1% 12.5% 20.7%
ROA (Net income/ Total Assets) 3.94% 7.1% 8.89% 12.2% 7.58% 12.5%
Assets 1 594.3 623.4 813.8 992 1,146 1,354
Book Value Per Share 2 13.90 15.40 17.40 20.90 23.40 28.60
Cash Flow per Share 2 0.0200 0.9200 0.4800 0.0500 0.4400 1.050
Capex 1 77.2 19.6 86.6 108 67.2 128
Capex / Sales 15.89% 3.36% 15.51% 14.62% 7.26% 11.44%
Announcement Date 01/10/18 23/08/19 18/08/20 24/08/21 24/08/22 16/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
VIKRAM THERMO (INDIA) LIMITED Stock Vikram Thermo (India) Limited
+30.31% 75.71M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.98% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.34% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.52% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.59% 329B
ABBVIE INC. Stock AbbVie Inc.
+4.07% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.21% 240B
NOVARTIS AG Stock Novartis AG
+9.66% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-6.83% 200B
AMGEN INC. Stock Amgen Inc.
+7.09% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VIKRAMTH6 Stock
  4. Financials Vikram Thermo (India) Limited